15 related articles for article (PubMed ID: 2532029)
1. In vitro evaluation of the PEtU-PDMS material immunocompatibility: the influence of surface topography and PDMS content.
Spiller D; Mirtelli C; Losi P; Briganti E; Sbrana S; Counoupas S; Kull S; Tonlorenzi S; Soldani G
J Mater Sci Mater Med; 2009 Dec; 20(12):2511-20. PubMed ID: 19756971
[TBL] [Abstract][Full Text] [Related]
2. Receptor-mediated phagocytosis in human neutrophils is associated with increased formation of inositol phosphates and diacylglycerol. Elevation in cytosolic free calcium and formation of inositol phosphates can be dissociated from accumulation of diacylglycerol.
Fällman M; Lew DP; Stendahl O; Andersson T
J Clin Invest; 1989 Sep; 84(3):886-91. PubMed ID: 2527254
[TBL] [Abstract][Full Text] [Related]
3. An immobile subset of plasma membrane CD11b/CD18 (Mac-1) is involved in phagocytosis of targets recognized by multiple receptors.
Graham IL; Gresham HD; Brown EJ
J Immunol; 1989 Apr; 142(7):2352-8. PubMed ID: 2538507
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of inhibition of immunoglobulin G-mediated phagocytosis by monoclonal antibodies that recognize the Mac-1 antigen.
Brown EJ; Bohnsack JF; Gresham HD
J Clin Invest; 1988 Feb; 81(2):365-75. PubMed ID: 2963020
[TBL] [Abstract][Full Text] [Related]
5. Osmotic stress and the freeze-thaw cycle cause shedding of Fc and C3b receptors by human polymorphonuclear leukocytes.
Takahashi T; Inada S; Pommier CG; O'Shea JJ; Brown EJ
J Immunol; 1985 Jun; 134(6):4062-8. PubMed ID: 3157755
[TBL] [Abstract][Full Text] [Related]
6. Monokines released during short-term Fc gamma receptor phagocytosis up-regulate polymorphonuclear leukocytes and monocyte-phagocytic function.
Simms HH; Gaither TA; Fries LF; Frank MM
J Immunol; 1991 Jul; 147(1):265-72. PubMed ID: 1828823
[TBL] [Abstract][Full Text] [Related]
7. Polymorphonuclear cell phagocytosis and surface receptor modulation after extracorporeal circulation.
Busnach G; Brando B; Cappelleri A; Sommaruga E; Brunati C; Minetti L
ASAIO Trans; 1989; 35(3):361-4. PubMed ID: 2532029
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
